Reactions that alter organic scaffolds by a single atom are already proving useful, but time will tell if they’ll ...

A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation ...

IR Japan Holdings, an investor relations firm, reports approximately 70 foreign activist companies operating in Japan as of ...

&EN senior editor Craig Bettenhausen reports from New York City, visiting the climate chemistry start-ups Aircela, which is ...

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...

While their functions are diverse, myosins are similar in structure. NMII is so much like cardiac myosin, which keeps the ...